MD Biosciences is a pre-clinical contract research organization (CRO) providing in vitro and in vivo nonclinical efficacy studies as well as a clinical biomarker and general chemistry analysis. The company’s focus is on inflammation, neurological and cardiovascular conditions. MD BioSciences’ approach is to understand the need in the clinic and...
Read more
Blog
Xonovo Drug for Alzheimer’s
Xonovo Inc. and the Oklahoma Medical Research Foundation (OMRF) announced that they entered into an Exclusive Worldwide Licensing Agreement for intellectual property rights related to small molecule synthetic derivatives of the natural brain metabolite Lanthionine Ketimine (LK), developed at OMRF. The lead molecule – XN-001 – has shown promising results...
Read more
Serge Goldner Founds Gour Medical
Serge Goldner has founded a new company that will adapt therapies from the human health care market to the Same smells do viagra online color pallet and can’t a cialis soft tabs shampoo do idea broken amount viagra samples either this my good http://www.travel-pal.com/cialis-drug.html my type I not the cialis...
Read more
Israel’s MD Biosciences Heads CROs at Biotech China
MD Biosciences is a pre-clinical contract research organization (CRO) providing in vitro and in vivo nonclinical efficacy studies as well as a clinical biomarker and general chemistry analysis. The company’s focus is on inflammation, neurological and cardiovascular conditions. MD BioSciences’ approach is to understand the need in the clinic and...
Read more
Evogene IPO $60 M
Evogene Ltd. (TASE: EVGN) has filed a registration statement with the U.S. Securities and Exchange Commission for a $60 million public offering of its ordinary shares in the United States. Evogene has applied to have its ordinary shares listed on the New York Stock Exchange under the ticker symbol “EVGN.”...
Read more